Celgene Beats Estimates, Raises Earnings Outlook

Celgene Beats Estimates, Raises Earnings Outlook

Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers

Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers

4 Tech and Biotech Stocks With Momentum to Watch

4 Tech and Biotech Stocks With Momentum to Watch

Midday Report: NetSuite Soars on Oracle Deal; Ford, Boeing Slide

Midday Report: NetSuite Soars on Oracle Deal; Ford, Boeing Slide

Facebook Blows Away Estimates, Stock Soars to All-Time High

Facebook Blows Away Estimates, Stock Soars to All-Time High

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure

Amgen Still Has Many Ways to Win

Amgen Still Has Many Ways to Win

Jim Cramer Likes UTX, Says Gilead Has Peaked, Sees a Bottom for Oil

Jim Cramer Likes UTX, Says Gilead Has Peaked, Sees a Bottom for Oil

DuPont Beats Earnings Ahead of Dow Chemical Merger

DuPont Beats Earnings Ahead of Dow Chemical Merger

Why Gilead Can't Easily Copy Celgene's 'Partner Partner Partner' Deal-Making Playbook

Why Gilead Can't Easily Copy Celgene's 'Partner Partner Partner' Deal-Making Playbook